March 2020 Archives

Russian Federation Pharma – March 2020 update

June 8, 2020

No comments

News

Russian Federation Pharma – March 2020 update

KYBORA is an experienced global advisory firm that maintains close direct connections with the top 20 market leaders through regular updates and networking

Russian Federation Pharma – March 2020 update

Recent blog post.

KYBORA is happy to announce that Khai Meng Ang has joined its team as Senior Advisor for China.

KYBORA is pleased to announce that its client Megalabs has acquired acquired Fr!ska.

KYBORA is pleased to announce the licensing of Daewoong’s development stage IPF therapy (Bersiporocin) to CS Pharmaceuticals for the Greater China region.

KYBORA is pleased to announce that its trademarks have been approved and registered by the Chinese government.

KYBORA is pleased to announce the partnering of ORLADEYO® (berotralstat) in Latin America.

TYPE & ENTER:

Recent blog post.

Tags.

TYPE & ENTER: